Yahoo Web Search

Search results

  1. 2 days ago · The OxfordAstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19.

  2. 5 days ago · AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases. The deal between the parties was announced in March 2024. AstraZeneca made a $1.05bn payment for all outstanding shares of Amolyt Pharma, free of cash and debt. The transaction includes an upfront payment of $800m and an ...

  3. 2 days ago · Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress.

  4. 2 days ago · AstraZeneca PLC will announce its Q2 earnings next Thursday, 25th July. In Q1, the company showed 19% year-on-year revenue growth and 13% EPS growth. Guidance for 2024 is for double-digit growth ...

  5. 6 days ago · AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including ...

  6. 2 days ago · Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point ...

  7. Get the latest AstraZeneca PLC (LON: AZN) stock price quote with financials, statistics, dividends, charts and more.

  1. People also search for